GILEAD SCIENCES, INC. (GILD) Form 10-K Annual Reports
GILEAD SCIENCES, INC. (GILD) is a publicly traded company on the Nasdaq, categorized under SIC 2836 (Biological Products, (No Diagnostic Substances)). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: GILD
CIK: 882095
Exchange: Nasdaq
SIC 2836: Biological Products, (No Diagnostic Substances)
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 12/31/2016 12:00:00 AM
Lead Engagement PartnerRichard Jackson
Audit LocationSan Mateo, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-10-16 | 2026-10-15 | FORM 4 | 0001310204-26-000031 | View SEC Doc Filr Page |
| 4 | 2026-10-16 | 2026-10-15 | FORM 4 | 0001782135-26-000035 | View SEC Doc Filr Page |
| 144 | 2026-10-15 | — | 144 Filing | 0001950047-26-010250 | View SEC Doc Filr Page |
| 144 | 2026-10-15 | — | 144 Filing | 0001950047-26-010246 | View SEC Doc Filr Page |
| 4 | 2026-10-02 | 2026-10-01 | FORM 4 | 0001638643-26-000035 | View SEC Doc Filr Page |
| 4 | 2026-09-23 | 2026-09-22 | FORM 4 | 0001927648-26-000005 | View SEC Doc Filr Page |
| 4 | 2026-09-16 | 2026-09-15 | FORM 4 | 0001310204-26-000029 | View SEC Doc Filr Page |
| 4 | 2026-09-16 | 2026-09-15 | FORM 4 | 0001782135-26-000033 | View SEC Doc Filr Page |
| 144 | 2026-09-15 | — | 144 Filing | 0001950047-26-009482 | View SEC Doc Filr Page |
| 144 | 2026-09-15 | — | 144 Filing | 0001950047-26-009467 | View SEC Doc Filr Page |
| 4 | 2026-09-11 | 2026-09-10 | FORM 4 | 0001310204-26-000027 | View SEC Doc Filr Page |
| 4 | 2026-09-11 | 2026-09-10 | FORM 4 | 0001739515-26-000011 | View SEC Doc Filr Page |
| 4 | 2026-09-11 | 2026-09-10 | FORM 4 | 0001782135-26-000031 | View SEC Doc Filr Page |
| 4 | 2026-09-11 | 2026-09-10 | FORM 4 | 0002110603-26-000013 | View SEC Doc Filr Page |
| 4 | 2026-09-11 | 2026-09-10 | FORM 4 | 0001638643-26-000033 | View SEC Doc Filr Page |
| 4 | 2026-09-02 | 2026-09-01 | FORM 4 | 0001638643-26-000031 | View SEC Doc Filr Page |
| 4 | 2026-08-27 | 2026-08-26 | FORM 4 | 0001213307-26-000005 | View SEC Doc Filr Page |
| 144 | 2026-08-26 | — | 144 Filing | 0001950047-26-008716 | View SEC Doc Filr Page |
| N-PX | 2026-08-26 | 2026-06-30 | N-PX Filing | 0001123292-26-001172 | View SEC Doc Filr Page |
| 4 | 2026-08-21 | 2026-08-20 | FORM 4 | 0001771814-26-000005 | View SEC Doc Filr Page |
| 144 | 2026-08-20 | — | 144 Filing | 0001950047-26-008471 | View SEC Doc Filr Page |
| 4 | 2026-08-18 | 2026-08-17 | FORM 4 | 0001310204-26-000024 | View SEC Doc Filr Page |
| 4 | 2026-08-18 | 2026-08-17 | FORM 4 | 0001782135-26-000028 | View SEC Doc Filr Page |
| 144 | 2026-08-17 | — | 144 Filing | 0001950047-26-008219 | View SEC Doc Filr Page |
| 144 | 2026-08-17 | — | 144 Filing | 0001950047-26-008208 | View SEC Doc Filr Page |